Skip to main content

Table 3 Patient summary statistics

From: Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial

  Intervention Control pvalue
All Patients* (n) 5560 5820  
Consenting Patients** (n) 2858 2788
Mean HbA1c at baseline (SD)** 7.11 (0.43) 7.19 (0.52) 0.32
Mean years since T2DM diagnosis (SD)** 7.9 (2.54) 8.0 (2.90) 0.80
Mean number of insulin-eligible patients at time of workshop per physician (n,%) 10.9 (5.80) 11.3 (7.09) 0.70
Mean HbA1c of insulin-eligible patients at time of workshop (SD)** 8.6 (0.59) 8.6 (0.76) 0.74
Mean number of patients newly prescribed insulin between Workshop and 12 months post (SD)** 1.8 (1.87) 1.9 (1.71) 0.91
Mean number of office visits during study for insulin-eligible patients at the time of insulin initiation (SD) 6.0 (2.24) 5.9 (2.39) 0.84
Mean elapsed time in days, workshop to first office visit for insulin-eligible patients at the time of insulin initiation (SD) 45.3 (32.92) 65.4 (53.99) 0.04
  1. *All patients with T2DM in practice.
  2. **Data from consenting patients’ charts only.